Cardiomyopathy related to antimalarial therapy with illustrative case report

Cardiology

Volumn 107, Issue 2, 2007, Pages 73-80

  Costedoat Chalumeau, Nathalie ^a   Hulot, Jean Sebastien ^a   Amoura, Zahir ^a   Delcourt, Annick ^a   Maisonobe, Thierry ^a   Dorent, Richard ^a   Bonnet, Nicolas ^a   Sablé, Régis ^a   Lechat, Philippe ^a   Wechsler, Bertrand ^a   Piette, Jean Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cardiomyopathy; Chloroquine; Complete atrioventricular block; Hydroxychloroquine; Toxicity

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; COLLAGENAN; FUROSEMIDE; HYDROCORTISONE; HYDROXYCHLOROQUINE; PRAVASTATIN; PREDNISONE; RAMIPRIL; SALICYLIC ACID; SPIRONOLACTONE;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CONGESTIVE HEART FAILURE; DISCOID LUPUS ERYTHEMATOSUS; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG WITHDRAWAL; FEMALE; HEART MUSCLE BIOPSY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART TRANSPLANTATION; HUMAN; MUSCLE BIOPSY; PRIORITY JOURNAL;

ANTIMALARIALS; CHLOROQUINE; FEMALE; HEART BLOCK; HEART DISEASES; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED;

EID: 33847028652     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094079     Document Type: Article

References (37)

1. Estes ML, Ewing-Wilson D, Chou SM, Mitsumoto H, Hanson M, Shirey E, et al: Chloroquine neuromyotoxicity. Clinical and pathologic perspective. Am J Med 1987;82:447-455.
2. Keating RJ, Bhatia S, Amin S, Williams A, Sinak LJ, Edwards WD: Hydroxychloroquine-induced cardiotoxicity in a 39-yearold woman with systemic lupus erythematosus and systolic dysfunction. J Am Soc Echocardiogr 2005;18:981.
3. Roos JM, Aubry MC, Edwards WD: Chloroquine cardiotoxicity: clinicopathologic features in three patients and comparison with three patients with Fabry disease. Cardiovasc Pathol 2002;11:277-283.
4. Ratliff NB, Estes ML, Myles JL, Shirey EK, McMahon JT: Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy. N Engl J Med 1987;316:191-193.
5. Freihage JH, Patel NC, Jacobs WR, Picken M, Fresco R, Malinowska K, et al: Heart transplantation in a patient with chloroquine-induced cardiomyopathy. J Heart Lung Transplant 2004;23:252-255.
6. Veinot JP, Mai KT, Zarychanski R: Chloroquine related cardiac toxicity. J Rheumatol 1998;25:1221-1225.
7. Naqvi TZ, Luthringer D, Marchevsky A, Saouf R, Gul K, Buchbinder NA: Chloroquine-induced cardiomyopathy-echocardiographic features. J Am Soc Echocardiogr 2005;18:383-387.
8. Wray R, Iveson M: Complete heart block and systemic lupus erythematosus. Br Heart J 1975;37:982-983.
9. Ogola ES, Muita AK, Adala H: Chloroquine related complete heart block with blindness: case report. East Afr Med J 1992;69:50-52.
10. Piette JC, Guillevin L, Chapelon C, Wechsler B, Bletry O, Godeau P: Chloroquine cardiotoxicity. N Engl J Med 1987;317:710-711.
11. Godeau P, Guillevin L, Fechner J, Bletry O, Herreman G: Disorders of conduction in lupus erythematosus:frequency and incidence in a group of 112 patients (author's transl). Ann Med Interne (Paris) 1981;132:234-240.
12. August C, Holzhausen HJ, Schmoldt A, Pompecki R, Schroder S: Histological and ultrastructural findings in chloroquine-induced cardiomyopathy. J Mol Med 1995;73:73-77.
13. Iglesias Cubero G, Rodriguez Reguero JJ, Rojo Ortega JM: Restrictive cardiomyopathy caused by chloroquine. Br Heart J 1993;69:451-452.
14. Baguet JP, Tremel F, Fabre M: Chloroquine cardiomyopathy with conduction disorders. Heart 1999;81:221-223.
15. Cervera A, Espinosa G, Font J, Ingelmo M: Cardiac toxicity secondary to long term treatment with chloroquine. Ann Rheum Dis 2001;60:301.
16. Magnussen I, de Fine Olivarius B: Cardiomyopathy after chloroquine treatment. Acta Med Scand 1977;202:429-431.
17. Guedira N, Hajjaj-Hassouni N, Srairi JE, el Hassani S, Fellat R, Benomar M: Third-degree atrioventricular block in a patient under chloroquine therapy. Rev Rhum Engl Ed 1998;65:58-62.
18. Charlier P, Cochand-Priollet B, Polivka M, Goldgran-Toledano D, Leenhardt A: Chloroquine cardiomyopathy revealed by complete atrio-ventricular block. A case report. Arch Mal Coeur Vaiss 2002;95:833-837.
19. Duvic C, Pats B, Rouvier B: Complete heart block following chronic chloroquine treatment. Rev Med Interne 2000;21:462-463.
20. Edwards AC, Meredith TJ, Sowton E: Complete heart block due to chronic chloroquine toxicity managed with permanent pacemaker. Br Med J 1978;1:1109-1110.
21. Ladipo GO, Essien EE, Andy JJ: Complete heart block in chronic chloroquine poisoning. Int J Cardiol 1983;4:198-200.
22. Oli JM, Ihenacho HN, Talwar RS: Chronic chloroquine toxicity and heart block: a report of two cases. East Afr Med J 1980;57:505-507.
23. Teixeira RA, Martinelli Filho M, Benvenuti LA, Costa R, Pedrosa AA, Nishioka SA: Cardiac damage from chronic use of chloroquine: a case report and review of the literature. Arq Bras Cardiol 2002;79:85-88.
24. Rewcastle NB, Humphrey JG: Vacuolar myopathy: clinical, histochemical, and microscopic study. Arch Neurol 1965;12:570-582.
25. Whisnant JP, Espinosa RE, Kierland RR, Lambert EH: Chloroquine neuromyopathy. Mayo Clin Proc 1963;38:501-513.
26. Reuss-Borst M, Berner B, Wulf G, Muller GA: Complete heart block as a rare complication of treatment with chloroquine. J Rheumatol 1999;26:1394-1395.
27. Verny C, de Gennes C, Sebastien P, Le Thi HD, Chapelon C, Piette JC, et al: Heart conduction disorders in long-term treatment with chloroquine. Two new cases. Presse Med 1992;21:800-804.
28. Ihenacho HN, Magulike E: Chloroquine abuse and heart block in Africans. Aust N Z J Med 1989;19:17-21.
29. Fellahi JL, Dumazer P, Delayance S, Vernier I, Conte JJ: Cardiomyopathy under treatment with hydroxychloroquine disclosed by complete auriculoventricular block. Rev Med Interne 1993;14:275-276.
30. McAllister HA Jr, Ferrans VJ, Hall RJ, Strickman NE, Bossart MI: Chloroquine-induced cardiomyopathy. Arch Pathol Lab Med 1987;111:953-956.
31. Hughes JT, Esiri M, Oxbury JM, Whitty CW: Chloroquine myopathy. Q J Med 1971;40:85-93.
32. Nord JE, Shah PK, Rinaldi RZ, Weisman MH: Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature. Semin Arthritis Rheum 2004;33:336-351.
33. Case records of the Massachusetts General Hospital: Weekly clinicopathological exercises. Case 38-1988. A 58-year-old woman with fever, sweats, congestive heart failure, and lymphadenopathy after treatment for a diagnosis of systemic lupus erythematosus. N Engl J Med 1988;319:768-781.
34. Physician's Desk Reference. Available at: http://www.pdr.net;2005.
35. Neville HE, Maunder-Sewry CA, McDougall J, Sewell JR, Dubowitz V: Chloroquine-induced cytosomes with curvilinear profiles in muscle. Muscle Nerve 1979;2:376-381.
36. Mackenzie AH: Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Am J Med 1983;75:40-45.
37. Easterbrook M: An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine. J Rheumatol 1999;26:1866-1868.